Dentsply Sirona Gets Analyst Upgrade After Positive Mixture Of Preliminary Results, Update

On Wednesday, Dentsply Sirona Inc XRAY announced interim FY22 sales above the high end of the company's prior outlook range of $3.85 billion to $3.88 billion.
FY22 adjusted EPS is expected to be within the company's prior outlook range of $1.90 to $2.00.
William Blair writes that this was a welcomed preannouncement that shows a stabilizing organization after several quarters of declining EPS expectations.
Management also provided additional high-level details around long-term strategy at an investor conference that it expects will get the company to an EPS exit rate of $3.00 by 2025.
The analyst says that management targets a double-digit EPS CAGR after it works through near-term headwinds and implements new strategies.
William Blair upgraded Dentsply Sirona to a Market Perform rating as the analyst looked for more signs of durable execution.
Price Action: XRAY shares are up 1.55% at $35.66 on the last check Thursday.